F/M Investments’s AbbVie ABBV Stock Holding History

F/M Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.17M	Sell	24,521 -308	-1%	-$66.3K	0.31%	66
2026 Q1	$5.4M	Sell	24,829 -38,833	-61%	-$8.61M	0.36%	59
2025 Q4	$14.5M	Sell	63,662 -2,112	-3%	-$481K	0.55%	39
2025 Q3	$15.2M	Sell	65,774 -850	-1%	-$173K	0.59%	33
2025 Q2	$12.4M	Buy	66,624 +7,226	+12%	+$1.34M	0.45%	42
2025 Q1	$12.4M	Buy	59,398 +27	+0%	+$5.25K	0.5%	42
2024 Q4	$10.6M	Buy	59,371 +7,226	+14%	+$1.33M	0.39%	53
2024 Q3	$19M	Sell	52,145 -3,711	-7%	-$693K	0.6%	32
2024 Q2	$9.56M	Buy	55,856 +54,351	+3,611%	+$9M	0.35%	99
2024 Q1	$274K	Buy	1,505 +145	+11%	+$25K	0.19%	57
2023 Q4	$211K	Sell	1,360 -71	-5%	-$10.4K	0.12%	80
2023 Q3	$213K	Buy	+1,431	New	+$210K	0.16%	68
2023 Q2	–	Sell	-1,275	Closed	-$203K	–	75
2023 Q1	$203K	Hold	1,275	–	–	0.2%	60
2022 Q4	$206K	Buy	+1,275	New	+$195K	0.25%	50
2022 Q3	–	Sell	-1,962	Closed	-$221K	–	33
2022 Q2	$221K	Sell	1,962 -11	-0.6%	-$1.68K	0.17%	59
2022 Q1	$320K	Buy	1,973 +9	+0.5%	+$1.31K	0.26%	43
2021 Q4	$266K	Hold	1,964	–	–	0.19%	54
2021 Q3	$212K	Buy	1,964 +2	+0.1%	+$229	0.15%	75
2021 Q2	$221K	Sell	1,962 -1,685	-46%	-$190K	0.17%	59
2021 Q1	$395K	Buy	3,647 +1,625	+80%	+$174K	0.31%	51
2020 Q4	$217K	Buy	+2,022	New	+$194K	0.19%	52

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

F/M Investments's ABBV Position: Q2 2026 in Review

F/M Investments reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $66.3K and leaving 24,521 shares worth $6.17M. The position accounts for 0.31% of the portfolio, ranked #66.

F/M Investments first reported a position in ABBV in Q4 2020 and has held it in 21 quarters since. The position peaked at $19M in Q3 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

F/M Investments held 24,521 shares of AbbVie worth $6.17M as of Q2 2026.
F/M Investments sold 308 AbbVie shares in Q2 2026, an estimated $66.3K.
AbbVie made up 0.31% of F/M Investments's portfolio in Q2 2026, its #66 holding.
F/M Investments first reported a position in AbbVie in Q4 2020 and has held it in 21 quarters since.
F/M Investments's AbbVie position peaked at $19M in Q3 2024.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.